Products
Platform
Research
Market
Learn
Partner
Support
IPO

P

PARKHOSPS

₹14,904 / 92 shares

RHP/DRHP

Issue Date

10 Dec - 12 Dec'25

Price Range

₹154 - ₹162

Lot Size

92

IPO Size

₹920 Cr

Park Medi World IPO Listing Details

Listing On

17 Dec'25

Issue Price

₹162

Listed Price

₹ 155.6

Retail Gain/Listing Gain

-3.95%

Schedule of Park Medi World IPO

Start date

10/12/2025

End date

12/12/2025

Allotment of bids

15/12/2025

Refund Initiation

16/12/2025

Listing on exchange

17/12/2025

(Last updated on 12 Dec 2025 04:45 PM)

The IPO of Park Medi World comprises a fresh issue and an offer for sale. Fresh issue aggregates up to ₹770 crores while offer for sale aggregates up to ₹150 crores. The total offer size aggregates up to ₹920 crores. The price band is ₹154 to ₹162 per share, and it’s a 100% book-built offer.

Park Medi World IPO opens on December 10, 2025 and closes on December 12, 2025. The allotment of shares will take place on December 15, 2025. The credit of shares to the Demat account will take place on December 16, 2025. The initiation of refunds will take place on December 16, 2025. The listing of shares will take place on December 17, 2025.

The lot size of shares in the IPO is 92. The minimum number of lots in the IPO for retail investors is 1. The minimum investment amount required by a retail investor is ₹14,904 based on the upper price.

Park Medi World is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of September 30, 2024. It operates a network of 13 NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan.

The company plans to utilise the IPO proceeds for:

  • Repayment/ prepayment, in full or in part, of certain outstanding borrowings availed by the company and certain of its subsidiaries
  • Funding capital expenditure for development of new hospital by its subsidiary, Park Medicity (NCR)
  • Funding capital expenditure for purchase of medical equipment by the company and its certain subsidiaries, Blue Heavens and Ratangiri
  • Unidentified inorganic acquisitions and general corporate purposes

The domestic healthcare industry comprises the following major segments: healthcare delivery (hospitals, clinics), pharmaceuticals, medical devices, diagnostic services, medical equipment, and other support services to the healthcare players. Out of these, healthcare delivery forms the major part, the industry grew from ₹3.9 trillion in Fiscal 2019 to ₹ 6.3 trillion in Fiscal 2024 growing at a CAGR of approximately 10%.

From Fiscal 2024 to Fiscal 2028, it is expected to grow at a CAGR of approximately 10-12% to reach ₹ 9.4-9.8 trillion in FY28P. This growth in the healthcare industry is driven by factors such as an aging population, increased incidence of lifestyle diseases, growing healthcare awareness, technology adoption and a growing affluent middle class.

Park Medi World is the second largest private hospital chain in North India with an aggregate bed capacity of 3,000 beds, and the largest private hospital chain in terms of bed capacity in Haryana with 1,600 beds located in the state as of September 30, 2024.

It operates a network of 13 NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan, each committed to providing high-quality and affordable medical services across a diverse range of specialties.

  • Second largest chain of private hospitals in North India and largest private hospital chain in Haryana
  • Delivering high-quality and affordable healthcare with a diverse specialty mix
  • Track record of successfully acquiring and integrating hospitals
  • Strong operational and financial performance with diversified payor mix
  • Doctor led professional management team with industry experience
  • Inability to retain and attract doctors, nurses and medical professionals and support staff could adversely affect business and results of operations
  • Any adverse developments in Haryana could have an adverse effect on business, results of operations and financial condition
  • It may not be able to complete or achieve the expected benefits from current or future acquisitions
  • It may not be successful in developing its proposed hospitals and may not achieve operating capacities
  • Any adverse developments in the demand or income from specialties such as internal medicine, neurology, urology, gastroenterology, cardiology, general surgery and orthopedics may adversely affect business
  • Inability to maintain or increase hospital occupancy rates at sufficient levels may adversely affect operation efficiencies
  • Delays in receiving payments or the rejection of claims could adversely impact business
  • Subject to various operational, reputational, medical and legal claims or other actions arising from the provision of healthcare services
  • Failure to obtain or renew approvals, licenses, registrations and permits may adversely affect business
  • Any negative publicity or allegations may adversely affect the level of trust in services
Loading chart...

Anchor Investor Bidding Date

Anchor portion of the IPO opens for bidding on December 9, 2025.

IPO Registrar and Book Running Lead Managers

  • IPO Registrar: KFin Technologies
  • Book Running Lead Managers: Nuvama Wealth Management, CLSA India, DAM Capital Advisors and Intensive Fiscal Services

Park Medi World offers over 30 super specialty and specialty services, including internal medicine, neurology, urology, gastroenterology, general surgery, orthopedics and oncology. As of September 30, 2024, it had a dedicated team of 891 doctors and 1,912 nurses across hospitals, delivering clinical and patient care.

The revenue from operations of Park Medi World grew from ₹1254.595 crores in FY 23 to ₹1393.570 crores in FY 25. Its bed capacity increased from 2250 in FY 23 to 3000 in FY 25. Over the years, it has undertaken a series of acquisitions acquiring seven hospitals across North India, including in Faridabad, Karnal, Ambala, Behror, Palam Vihar, Sonipat and Mohali.

It adopted a cluster-based approach to grow its network of hospitals leveraging the benefits of proximity between hospitals leading to operational efficiencies and enabling it to benefit from economies of scale.

Park Medi World is the second largest private hospital chain in North India. It operates a network of 13 NABH accredited multi-super specialty hospitals under the ‘Park’ brand, of which seven hospitals are also NABL accredited, with eight hospitals in Haryana, one hospital in New Delhi, two hospitals in Punjab and two hospitals in Rajasthan.

  • Log in to your Kotak Securities Demat account - Log in to your Demat account to access IPO investments. Next, select the current IPO section.
  • Specify IPO details - Enter the number of lots and the price you wish to apply for.
  • Enter UPI ID - After entering your UPI ID, click submit. This will place your bid with the exchange.
  • Mandate Notification - Your UPI app will receive a mandate notification to block funds.
  • Approve Request - Your funds will be blocked once you approve the mandate request on your UPI.
Apply for Park Medi World IPO